Ergoteles’s Crinetics Pharmaceuticals CRNX Stock Holding History

Ergoteles’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$412K	Buy
2023 Q1	$259K	Sell
2022 Q4	$349K	Buy